tiprankstipranks
Viridian Therapeutics (VRDN)
NASDAQ:VRDN

Viridian Therapeutics (VRDN) Technical Analysis

981 Followers

Technical Sentiment

Overall Consensus
Strong Sell
3Bullish
5Neutral
14Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Viridian Therapeutics’s (VRDN) Moving Averages Convergence Divergence (MACD) indicator is -0.40, suggesting Viridian Therapeutics is a Buy.
Viridian Therapeutics’s (VRDN) 20-Day exponential moving average is 18.04, while Viridian Therapeutics’s (VRDN) share price is $17.51, making it a Sell.
Viridian Therapeutics’s (VRDN) 50-Day exponential moving average is 18.54, while Viridian Therapeutics’s (VRDN) share price is $17.51, making it a Sell.

Viridian Therapeutics (VRDN) Pivot Points

Apr 28, 2024, 08:36 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
16.21
16.68
17.09
17.56
17.97
18.44
18.85
Fibonacci
16.68
17.01
17.22
17.56
17.89
18.10
18.44
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Viridian Therapeutics (VRDN) Moving Averages

Apr 28, 2024, 08:36 AM
Period
Simple
Exponential
MA5
17.59Sell
17.60Sell
MA10
17.65Sell
17.74Sell
MA20
18.15Sell
18.04Sell
MA50
18.71Sell
18.54Sell
MA100
18.69Sell
18.68Sell
MA200
18.56Sell
19.64Sell
Viridian Therapeutics’s (VRDN) 10-Day exponential moving average is 17.74, while Viridian Therapeutics’s (VRDN) share price is $17.51, making it a Sell.
Viridian Therapeutics’s (VRDN) 100-Day exponential moving average is 18.68, while Viridian Therapeutics’s (VRDN) share price is $17.51, making it a Sell.
Viridian Therapeutics’s (VRDN) stock price is $17.51 and Viridian Therapeutics’s (VRDN) 50-day simple moving average is 18.71, creating a Sell signal.
Viridian Therapeutics’s (VRDN) stock price is $17.51 and Viridian Therapeutics’s (VRDN) 100-day simple moving average is 18.69, creating a Sell signal.
Viridian Therapeutics’s (VRDN) stock price is $17.51 and Viridian Therapeutics’s (VRDN) 200-day simple moving average is 18.56, creating a Sell signal.

Viridian Therapeutics (VRDN) Technical Indicators

Apr 28, 2024, 08:36 AM
Name
Value
Implied Action
RSI (14)
44.87
Neutral
STOCH (9,6)
44.79
Neutral
STOCHRSI (14)
32.02
Neutral
MACD (12,26)
-0.40
Buy
ADX (14)
12.04
Buy
Williams %R
-66.83
Buy
CCI (14)
-60.83
Neutral
ATR (14)
1.11
-
Ultimate Oscillator
44.16
Neutral
ROC
-8.52
Sell
Viridian Therapeutics’s (VRDN) Relative Strength Index (RSI) is 44.87, creating a Neutral signal.
Viridian Therapeutics’s (VRDN) Trend Strength Indicator (ADX) is 12.04, creating a Buy signal.
Viridian Therapeutics’s (VRDN) Commodity Channel Index (CCI) is -60.83, creating a Neutral signal.
Viridian Therapeutics’s (VRDN) Price Rate of Change (ROC) is -8.52, creating a Sell signal.

FAQ

Is VRDN a Buy, Hold, or Sell?
Based on VRDN’s technical indicators, VRDN is a Strong Sell.
    What is VRDN’s RSI (14)?
    VRDN’s RSI (14) is 44.87, which suggests VRDN is a Neutral.
      What is VRDN’s MACD?
      VRDN’s MACD is -0.40, which suggests VRDN is a Buy.
        What is VRDN’s 5-day moving average?
        VRDN’s 5-day moving average is 17.59, which suggests VRDN is a Sell.
          What is VRDN’s 20-day moving average?
          VRDN 20-day moving average is 18.15, which suggests VRDN is a Sell.
            What is VRDN’s 50-day moving average?
            VRDN’s 50-day moving average is 18.71, which suggests VRDN is a Sell.
              What is VRDN’s 200-day moving average?
              VRDN’s 200-day moving average is 18.56, which suggests VRDN is a Sell.
                What is VRDN’s Williams % R (14)?
                VRDN’s Williams % R (14) is -66.83, which suggests VRDN is a Buy.
                  What is VRDN’s CCI (14)?
                  VRDN’s CCI (14) is -60.83, which suggests VRDN is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis